Godrej Agrovet Q1 FY27 Results & Concall Highlights: Revenue, Margins & Order Book
Published 25 Aug 2026 | Food Products | Market Cap: ₹11.1K Cr
Oil Palm Business: Expected high single-digit to early double-digit FFB (Fresh Fruit Bunch) volume growth over the next 3-5 years due to area expansion and multiple growth pillars. Animal Nutrition:** Expect continued volume growth (~7%), with stable EBIT per tonne guidance around INR 2,050-2,150 supported by premiumization and geographic expansion.
From Godrej Agrovet's Q1 FY27 earnings-call transcript · updated 25 Aug 2026.
Price
₹609
Market Cap
₹11.1K Cr
P/E Ratio
23.6
Revenue Rank
Margin Rank
How does Godrej Agrovet rank in Food Products?
Compare Godrej Agrovet against every Food Products company this quarter on revenue, margins and earnings-call signals.
Godrej Agrovet — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹2.3K Cr, net profit ₹102 Cr.
Full financials →📊 Revenue & Sales Performance
Rank 3- →Oil Palm Business: Expected high single-digit to early double-digit FFB (Fresh Fruit Bunch) volume growth over the next 3-5 years due to area expansion and multiple growth pillars.
- →Crop Care Business: Anticipated double-digit growth in revenues, with new product launches (Ashitaka, Takai, Ghassnash) gaining market traction, though short-term impact from delayed monsoon persists.
- →Animal Nutrition Business: Fish feed growing at 20%+, cattle feed dominating with 55-56% share and growing at 15%. Non-cattle feeds growing healthily with focus on profitable geographies and premiumization.
- →Dairy Business: Experiencing volume growth in value-added products, aiming for portfolio premiumization and route-to-market transformation for improved profitability.
- →Godrej Foods: Branded volumes growing (~6%) with Yummiez up 22%, focusing on building a higher-quality branded foods portfolio.
- →Bangladesh JV (ACI Godrej): Returning to strong double-digit volume, revenue, and profitability growth.
- →Overall, Godrej Agrovet targets sustainable double-digit growth, with clearer guidance expected by Q2 FY27 end.
📈 Profitability & Margins
Rank 3- →**Animal Nutrition:** Expect continued volume growth (~7%), with stable EBIT per tonne guidance around INR 2,050-2,150 supported by premiumization and geographic expansion.
- →**Oil Palm:** Anticipated high single-digit to early double-digit FFB volume growth over 3-5 years; EBITDA expected to grow beyond INR 500 crores with integrated value-added downstream expansion contributing an estimated 200 bps to overall EBITDA margin.
- →**Crop Care:** Recovery expected in H2 FY27 after a slow start due to delayed monsoon; guidance on segment revenue outlook to be clearer by end of Q2; portfolio diversification with new product launches supports growth.
- →**Astec LifeSciences:** Confident of over 20% revenue growth for FY27 with margin normalization and operational recovery continuing.
- →**Overall:** Management targets double-digit consolidated sales and PBT growth for FY27, with clearer visibility post Q2.
🏗️ Capital Expenditure Plans
Yes- →Godrej Agrovet has planned overall capex of around INR 300-350 crores at the business level, which includes ongoing and planned investments.
- →Key ongoing investments include:
- → - Integrated complex with the first phase kicked off this year.
- → - Specialty fats factory starting early ramp-up in the second half of the year.
- → - Upcoming refinery of specialty fats slated for rollout by end August/early September.
- → - Seed garden for future genetic work expected within 18-24 months.
- →Capex is planned in phases over 3-4 quarters and is assumed in current guidance.
- →The company targets a high IRR (16-18%) from these investments.
- →These capex projects aim to transform the oil palm business into a full integrated upstream-to-downstream value-added business, including specialty food ingredients.
- →No additional or unplanned capex beyond the guidance has been indicated.
💰 Fundraising & Capital Structure
No information- →There is no explicit mention of any current or future new fundraising through debt or equity in the provided transcript pages.
- →The company has discussed capex guidance, with a planned investment of around INR 300-350 crores already assumed in their business plans, indicating no new capital raising is anticipated for this purpose.
- →Capex investments include integrated complex and specialty investments aiming for high IRR (around 16%-18%).
- →Focus remains on capital allocation discipline and balance sheet efficiency, with improvements in net working capital and cash generation highlighted.
- →No references to upcoming equity issuance or debt raising were made in the discussions on business growth, expansions, or strategic plans.
📋 Order Book & Pipeline
No informationKey Metrics
Revenue
Margin
Capex
Fundraise
Order Book
Frequently Asked Questions
What were Godrej Agrovet Q1 FY27 results?
Oil Palm Business: Expected high single-digit to early double-digit FFB (Fresh Fruit Bunch) volume growth over the next 3-5 years due to area expansion and multiple growth pillars. Animal Nutrition:** Expect continued volume growth (~7%), with stable EBIT per tonne guidance around INR 2,050-2,150 supported by premiumization and geographic expansion.
What is Godrej Agrovet share price analysis?
Godrej Agrovet currently shows a below-average growth signal. The stock trades at a P/E of 23.6 with a market cap of ₹11,052 Cr. Investors should review the full earnings analysis for detailed insights.
Is Godrej Agrovet planning capital expenditure?
Godrej Agrovet has planned overall capex of around INR 300-350 crores at the business level, which includes ongoing and planned investments.
Keep Godrej Agrovet on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.